23 April 2024 - Medicure announced today that through its subsidiary, Medicure International, the US FDA has granted fast track designation ...
23 April 2024 - Today, the FDA approved lutetium Lu 177 dotatate (Lutathera, Advanced Accelerator Applications) for paediatric patients 12 ...
21 April 2024 - Xbrane Biopharma announce that the US FDA has issued a complete response letter to the Company’s ...
23 April 2024 - ALPHA Phase 3 trial showed first-in-class, oral, Factor D inhibitor as add-on to Ultomiris or Soliris ...
23 April 2024 - EMA has published a number of recommendations to address vulnerabilities in the production and delivery of medicines ...
23 April 2024 - PHARMAC is proposing to fund more treatments for people with a type of blood cancer, multiple ...
22 April 2024 - Acadia Pharmaceuticals today announced that Health Canada has accepted its new drug submission for trofinetide for the ...
19 April 2024 - Merck announced that Health Canada has approved a new indication for Prevymis (letermovir) for the prophylaxis ...
22 April 2024 - What is the strength of association between surrogate markers used as primary outcomes in clinical trials ...
22 April 2024 - Emblaveo was reviewed under EMA accelerated assessment procedure, used when a pharmaceutical product is of major ...
22 April 2024 - Ziftomenib is the first investigational treatment to be granted breakthrough therapy designation for NPM1 mutant AML. ...
22 April 2024 - Today, the FDA approved nogapendekin alfa inbakicept-pmln (Anktiva, Altor BioScience) with Bacillus Calmette-Guérin (BCG) for adult ...
22 April 2024 - The EMA has published a draft agenda for this week's CHMP meeting. ...
19 April 2024 - Alvotech, in agreement with Teva Pharmaceuticals, has signed an agreement with a strategic partner to bring to ...
22 April 2024 - EC approval based on robust development program confirming match to reference medicine in terms of safety, ...